Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

NCT03205163

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • Indiana Hemophilia and Thrombosis Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals & Clinics Iowa City, Iowa, United States
  • Michigan State University East Lansing, Michigan, United States
View Trial Details
Completed

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

NCT02234323

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Research Site Little Rock, Arkansas, United States
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site San Francisco, California, United States
View all 71 locations
View Trial Details
Completed

Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia

NCT02281500

Conditions
Afibrinogenemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +7 more
Locations
  • Northshore Long Island Jewish Medical Center New Hyde Park, New York, United States
  • S.S. Institute of Medical Sciences and Research Centre Davangere, Karnataka, India
  • St. Johns Medical College and Hospital Bangalore, India
  • Sahyadri Specialty Hospital Pune, India
View Trial Details
Completed

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

NCT02234310

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Indianapolis, Indiana, United States
View all 27 locations
View Trial Details
Completed

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

NCT02548143

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • UT Southwestern Medical Center Dallas, Texas, United States
  • Dr. Jose Eleuterio Gonzalez Monterrey University Hospital Monterrey, Nuevo León, Mexico
  • Hematology Research Center of the Russian Academy of Medical Sciences Moscow, Russia
  • Charlotte Maxeke Johannesburg Academic Hospital, Hemophilia Comprehensive Care Parktown, Gauteng, South Africa
View Trial Details

Related conditions